YAO-WEN KUOSHANG-GIN WUCHAO-CHI HOJIN-YUAN SHIH2021-08-242021-08-2420101556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650499456&doi=10.1097%2fJTO.0b013e3181f43274&partnerID=40&md5=1b43630794e9a8225f17e2c1b0b37b82https://scholars.lib.ntu.edu.tw/handle/123456789/579305[SDGs]SDG3anaplastic lymphoma kinase; carcinoembryonic antigen; echinoderm microtubule associated protein like 4; epidermal growth factor receptor; gefitinib; microtubule associated protein 4; unclassified drug; aged; article; bronchus biopsy; cancer growth; cancer staging; case report; cytology; diagnostic test accuracy study; drug efficacy; exon; female; fusion gene; gene mutation; gene sequence; human; human cell; human tissue; lung adenocarcinoma; lung aspiration; marker gene; molecular genetics; pleura effusion; priority journal; reverse transcription polymerase chain reaction; treatment response; Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Mutation; Oncogene Proteins, Fusion; Quinazolines; Receptor, Epidermal Growth FactorGood response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutationjournal article10.1097/JTO.0b013e3181f43274211022672-s2.0-78650499456